Study 3 Sample Clauses

The 'Study 3' clause defines the specific terms and conditions related to the third study or phase within a broader agreement, such as a research collaboration or clinical trial contract. This clause typically outlines the objectives, scope, timelines, and responsibilities associated with Study 3, detailing what activities will be conducted, who will perform them, and any deliverables or milestones expected. By clearly delineating the parameters of this particular study, the clause ensures that both parties understand their obligations and helps prevent misunderstandings or disputes regarding this phase of the project.
Study 3. The emotion response system in anorexia and bulimia nervosa: facial expression, subjective experience and physiology This chapter describes a study which extends the work in Chapter 3. As well as measuring facial expression and subjective response to emotional stimuli this study will measure physiology, namely skin conductance. Therefore, it provides the opportunity to investigate more objectively the emotion response system in people with an ED and to note any discrepancies across this system.
Study 3. As the data collected in this study was a subsample of Study 2, the contributions were the same.
Study 3. In Study 3, we manipulated the prominence of family ties in politics not only explicitly (as in Studies 1 and 2), but also through a subtler, more implicit approach. Examining the impact of the prominence of family ties in a more implicit approach is important because mere facts that politicians are tied by kinship do in itself not proof that nepotism is at play. However, the fact that family ties in politics are prominent may lead people to infer a pattern of family-based promotion. It is important to examine this in more detail because cues signaling nepotism often come in a subtle form, not explicitly referring to a kin relationship in conjunction with certain favors to family members as manipulated in the previous studies. Citizens of the U.S.A., for example, generally know that ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ is the wife of a former president, that ▇▇▇▇▇▇
Study 3. Factorial simulations
Study 3. The vignette approach used in the previous studies is useful for examining topics that are sensitive and difficult to manipulate. However, it is also criticized for its lack of realism (▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇, 2014). We, therefore, opted for a more realistic approach for Studies 3 and 4. In both Studies, participants were organizational employees who were asked to judge the employment of a specific person within their own organization. Both studies were conducted in Indonesia, which is relevant because it has been suggested that although nepotism is universal, its manifestation is to some extent influenced by cultural values (▇▇▇▇▇ & ▇▇▇▇▇▇▇, 2012). Indeed, collectivism among Ecuadorian managers was found to be associated with their tolerance toward the practice of nepotism (▇▇▇▇▇ & ▇▇▇▇▇▇▇, 2015). Thus, given the greater prevalence (and tolerance) of nepotism in collectivistic cultures the current Indonesian studies may be seen as a conservative test of the current hypotheses. In Indonesia, nepotism became an important public issue during the Indonesian reformation movement in 1998 (▇▇▇▇▇▇▇▇▇-Snape, 1999). Since then, nepotism is considered a violation of the Indonesian constitution (Republic of Indonesia Law Number 28 Year 1999). However, whereas the majority of Indonesians view nepotism as undesirable (Melano, 2017), it remains commonplace in Indonesian politics and businesses. For example, the political reign of the Banten province is firmly in the hands of the Atut family (▇▇▇▇ ▇▇▇▇ is a former Governor), where ▇▇▇▇'▇ relatives (e.g., son, mother, sisters, cousins, etc.) occupy various strategic political and business positions (Shatiri, 2013). The primary aim of Study 3 was to replicate our previous findings in this more realistic context. Guided by the previous studies, we further hypothesized that participants would primarily view the employment of kin (as compared to non-kin) as more unfair in terms of procedural fairness (Hypothesis 4). The low perception of procedural fairness would lead to the perception that the employment of kin is also unfair in terms of distributive fairness (Hypothesis 5). Participants were 228 employees (109 men, 119 women, Mage = 27.68, SDage = 8.11) of 10 different organizations in Indonesia. They were assigned to a 2 (Kinship: no kin vs. kin) × 2 (Competence: low vs. high) between-subjects design. They were given a lunch package as compensation for their participation.

Related to Study 3

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Study Population ‌ Infants who underwent creation of an enterostomy receiving postoperative care and awaiting enterostomy closure: to be assessed for eligibility: n = 201 to be assigned to the study: n = 106 to be analysed: n = 106 Duration of intervention per patient of the intervention group: 6 weeks between enterostomy creation and enterostomy closure Follow-up per patient: 3 months, 6 months and 12 months post enterostomy closure, following enterostomy closure (12-month follow-up only applicable for patients that are recruited early enough to complete this follow-up within the 48 month of overall study duration).

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in ▇▇▇▇ rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Study Design This includes a discussion of the evaluation design employed including research questions and hypotheses; type of study design; impacted populations and stakeholders; data sources; and data collection; analysis techniques, including controls or adjustments for differences in comparison groups, controls for other interventions in the State and any sensitivity analyses, and limitations of the study.